Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis

BACKGROUND: To evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) biomarkers in patients with probable cerebral amyloid angiopathy (CAA) according to the modified Boston criteria in a retrospective multicentric cohort. METHODS: Beta-amyloid 1-40 (Aβ40), beta-amyloid 1-42 (Aβ42), total tau...

Descripción completa

Detalles Bibliográficos
Autores principales: Margraf, Nils G., Jensen-Kondering, Ulf, Weiler, Caroline, Leypoldt, Frank, Maetzler, Walter, Philippen, Sarah, Bartsch, Thorsten, Flüh, Charlotte, Röcken, Christoph, Möller, Bettina, Royl, Georg, Neumann, Alexander, Brüggemann, Norbert, Roeben, Benjamin, Schulte, Claudia, Bender, Benjamin, Berg, Daniela, Kuhlenbäumer, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884145/
https://www.ncbi.nlm.nih.gov/pubmed/35237145
http://dx.doi.org/10.3389/fnagi.2022.783996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884145/
https://www.ncbi.nlm.nih.gov/pubmed/35237145
http://dx.doi.org/10.3389/fnagi.2022.783996

Ejemplares similares